Brainsway BRSYF
NASDAQ BRSYF
$15.13 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Brainsway (BRSYF) Common Equity (2018 - 2026)

Brainsway's (BRSYF) quarterly Common Equity came in at $440000.0 in Q2 2026, down 99.35% on a YoY basis from $68.1 million in Q2 2025, and little changed quarter-over-quarter from $439000.0 in Q1 2026.

Analysis

Brainsway (BRSYF) Common Equity (2018 - 2026) Analysis & Trends

Brainsway (BRSYF) has reported Common Equity for 9 consecutive years, with $440000.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Common Equity fell 99.35% year-over-year to $440000.0; the trailing twelve-month figure through Jun 2026 stood at $440000.0 (down 99.35% YoY), and the FY2025 full-year result was $430000.0, down 99.31% from the prior year.
  • Common Equity held at $440000.0 in Q2 2026 per BRSYF's latest filing, from $439000.0 in the prior quarter.
  • Across five years, Common Equity topped out at $68.1 million in Q2 2025 and bottomed at $363000.0 in Q1 2022.
  • Historically, Common Equity has averaged $14.7 million across 5 years, with a median of $416500.0 in 2025.
  • The sharpest annual moves came in 2022 and 2024: Common Equity plunged 99.41% in 2022, then soared 11675.34% in 2024.
  • Over 5 years, Common Equity stood at $45.4 million in 2022, then declined by 8.41% to $41.6 million in 2023, then jumped by 49.86% to $62.3 million in 2024, then sank by 99.31% to $430000.0 in 2025, then rose by 2.33% to $440000.0 in 2026.
  • According to Business Quant data, Common Equity over the past three periods registered $440000.0, $439000.0, and $430000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Abbott Laboratories 180.94 Bn 175.34 Bn 7.27 Bn 51.76 Bn
2 Intuitive Surgical 127.83 Bn 122.62 Bn 1.96 Bn 18.30 Bn
3 Medtronic 116.96 Bn 108.14 Bn 6.34 Bn 50.85 Bn
4 Stryker 104.44 Bn 100.97 Bn 4.50 Bn 23.99 Bn
5 Boston Scientific 63.87 Bn 63.33 Bn 3.85 Bn 25.17 Bn
6 Edwards Lifesciences 49.91 Bn 45.65 Bn 1.35 Bn 10.72 Bn
7 Alcon 33.06 Bn 31.60 Bn 1.68 Bn 21.60 Bn
8 Dexcom 32.22 Bn 30.27 Bn 830.00 Mn 2.62 Bn
9 Steris 20.68 Bn 20.20 Bn 684.20 Mn 7.22 Bn
10 Brainsway 592.58 Mn 529.41 Mn 12.77 Mn 440,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 440,000.00
Mar 31, 2026 439,000.00
Dec 31, 2025 430,000.00
Sep 30, 2025 418,000.00
Jun 30, 2025 68.13 Mn
Mar 31, 2025 415,000.00
Dec 31, 2024 62.31 Mn
Sep 30, 2024 367,000.00
Jun 30, 2024 42.98 Mn
Mar 31, 2024 367,000.00
Dec 31, 2023 41.58 Mn
Sep 30, 2023 365,000.00
Jun 30, 2023 365,000.00
Mar 31, 2023 364,000.00
Dec 31, 2022 45.40 Mn
Sep 30, 2022 363,000.00
Jun 30, 2022 363,000.00
Mar 31, 2022 363,000.00
Dec 31, 2021 57.33 Mn
Sep 30, 2021 58.26 Mn